Evidence map›Paper›PMID 36357545›Full record

ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2023

From degrader to producer: reversing the gallic acid metabolism of Pseudomonas putida KT2440.

Felipe M S Dias, Raoní K Pantoja, José Gregório C Gomez, Luiziana F Silva

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Felipe M S DiasDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, 05508-900, Brazil. felipe.morillo@crg.eu.ORCID http://orcid.org/0000-0001-5232-4312
Raoní K PantojaDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, 05508-900, Brazil.ORCID http://orcid.org/0000-0002-8427-0846
José Gregório C GomezDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, 05508-900, Brazil.ORCID http://orcid.org/0000-0003-4624-6113
Luiziana F SilvaDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, 05508-900, Brazil.ORCID http://orcid.org/0000-0002-2787-4977
Universidade de São Paulo · BRUniversitat Pompeu Fabra · ES

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 130434/2016-7Conselho Nacional de Desenvolvimento Científico e Tecnológico 308714/2019-9Conselho Nacional de Desenvolvimento Científico e Tecnológico 309086/2018-3
6 · The paper itself

Abstract

Gallic acid is a powerful antioxidant with multiple therapeutic applications, usually obtained from the acidic hydrolysis of tannins produced by many plants. As this process generates a considerable amount of toxic waste, the use of tannases or tannase-producing microorganisms has become a greener alternative over the last years. However, their high costs still impose some barriers for industrial scalability, requiring solutions that could be both greener and cost-effective. Since Pseudomonas putida KT2440 is a powerful degrader of gallic acid, its metabolism offers pathways that can be engineered to produce it from cheap and renewable carbon sources, such as the crude glycerol generated in biodiesel units. In this study, a synthetic operon with the heterologous genes aroG4, quiC and pobA* was developed and expressed in P. putida, based on an in silico analysis of possible metabolic routes, resulting in no production. Then, the sequences pcaHG and galTAPR were deleted from the genome of this strain to avoid the degradation of gallic acid and its main intermediate, the protocatechuic acid. This mutant was transformed with the vector containing the synthetic operon and was finally able to convert glycerol into gallic acid. Production assays in shaker showed a final concentration of 346.7 ± 0.004 mg L

Indexed as

Pseudomonas putidaGallic AcidGlycerolGallic AcidGlycerolAromatic compoundsGallic acidMetabolic engineeringMicrobial cell factoryPseudomonas putida KT2440Synthetic biology

Identifiers

PMID36357545
PMCPMC9649394
OpenAlexW4308773718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.